Most people who have had a cardiovascular blood test will be familiar with cholesterol, LDL, HDL, and triglycerides. High-sensitivity C-reactive protein, hs-CRP, is a different kind of marker. Rather than measuring lipids, it reflects the level of inflammation present in the body.

Understanding what hs-CRP measures, and equally what it does not tell us, is the purpose of this article. It is a test that appears increasingly in cardiovascular research and in clinical discussions, and like all tests in medicine, its value depends almost entirely on the context in which it is used.

What Is CRP, and Why “High-Sensitivity”?

C-reactive protein is produced by the liver in response to inflammation. In its standard form, CRP is used to detect active infection or significant inflammatory disease, levels rise sharply and visibly when something acute is happening in the body.

The high-sensitivity version of the test uses a more precise assay capable of detecting much lower levels, the kind of chronic, low-grade vascular inflammation that does not produce obvious symptoms but has been associated with cardiovascular risk in research studies. To understand more about the role chronic inflammation plays in heart disease, including atherosclerosis, pericarditis, and myocarditis, we cover this in our dedicated article.

It is important to be clear from the outset: hs-CRP is a non-specific marker. An elevated result indicates heightened inflammation somewhere in the body, it does not identify the source, confirm a cardiac diagnosis, or predict with certainty what will happen to any individual. This is why hs-CRP is never interpreted in isolation, and why its clinical role is as one input among many rather than a standalone guide to action.

What the Numbers Mean, and Their Limitations

These thresholds come from population-level research and provide a general framework, they are not diagnostic cut-offs. A result above 3 mg/L may reflect obesity, a recent minor illness, an autoimmune condition, physical exertion, or kidney disease, among many other causes. It does not, on its own, mean that cardiovascular disease is present or imminent.

The Role of hs-CRP in Cardiovascular Assessment

In research settings, elevated hs-CRP has been associated with increased cardiovascular risk at a population level. In clinical practice, its role is more nuanced and more limited.

Where hs-CRP has the most established relevance is in risk refinement, specifically in people who sit in an intermediate risk zone based on conventional factors, where additional information might help guide clinical decision-making. Even in this setting, it is one piece of a much larger puzzle. A full and personalised cardiovascular assessment takes into account clinical history, the presence of prior ischaemic heart disease or established CVD, vascular risk factors, family history, and, increasingly, structural investigations such as a coronary calcium score or CT coronary angiogram. These investigations provide direct information about the coronary arteries that a blood marker of inflammation cannot.

hs-CRP does not diagnose heart disease. It does not replace a clinical consultation. And a normal hs-CRP result does not mean cardiovascular risk is absent, particularly in someone who carries other significant risk factors such as elevated Lp(a), high blood pressure, diabetes, or a strong family history.

hs-CRP and Lp(a), Understanding Two Different Pathways

A 2024 study published in JAMA Cardiology examined the relationship between Lp(a), a genetically determined lipid particle, and hs-CRP across multiple large cohorts. We have previously covered what Lp(a) is and why it matters in detail.

The study found that elevated Lp(a) raised cardiovascular risk regardless of hs-CRP levels, whether inflammation was high or low. This is a scientifically important finding because it suggests these two markers reflect distinct biological pathways rather than the same underlying process.

What this means in practice is that a normal hs-CRP does not neutralise the risk associated with elevated Lp(a), and vice versa. The two markers are not interchangeable, and neither tells the full story on its own. This is a useful illustration of a broader principle: cardiovascular risk is multifactorial, and no single test captures it completely.

What Raises hs-CRP?

Because hs-CRP is a non-specific marker, many different conditions and lifestyle factors can elevate it, the majority of which are unrelated to cardiovascular disease. This is worth understanding before placing too much weight on a single result.

hs-CRP and Treatment, What the Evidence Does and Does Not Show

Some research, most notably the JUPITER trial, found that statin therapy reduced cardiovascular events in people with elevated hs-CRP and relatively normal LDL cholesterol. This generated significant interest in hs-CRP as a guide to treatment decisions. However, the JUPITER trial has been the subject of considerable debate, and its findings have not translated into a straightforward recommendation that hs-CRP alone should drive prescribing decisions.

Statins do have anti-inflammatory properties beyond their LDL-lowering effect, this is well established. But whether hs-CRP is the right marker to identify who benefits most from this effect, and in which clinical context, remains an area of ongoing discussion rather than settled guidance.

The honest position is that hs-CRP is a useful piece of information in selected patients, interpreted by a clinician who can weigh it against everything else known about that individual, their prior cardiovascular history, their vascular risk factor burden, their coronary calcium score, their CTCA findings if available, and their Lp(a) status. It is not a test that stands alone, and it is not a test whose result should prompt self-directed action.

Cardiovascular risk assessment is personal. No single blood test, including hs-CRP, can substitute for a full clinical evaluation by a doctor who knows your history, your investigations, and your individual circumstances.

Conclusion

If you have seen hs-CRP mentioned in your blood results or in a conversation with your doctor, this article is intended to help you understand what the test measures and where its limitations lie, not to suggest you should seek it out or act on the result independently.

hs-CRP is one piece of information among many. Its value lies in being interpreted alongside your full clinical picture, your prior cardiovascular history, your vascular risk factors, your Lp(a) status, and where relevant, structural investigations such as a coronary calcium score or CT coronary angiogram. That kind of personalised, comprehensive assessment is what cardiovascular risk management is built on, and no single blood test can substitute for it.

If you have concerns about your heart health, the most important step is a conversation with your GP or cardiologist.

More from Heart Matters

• Lipoprotein(a), The Inherited Heart Risk Most People Have Never Heard Of
• Inflammation and Heart Disease: The Hidden Driver Behind Atherosclerosis, Pericarditis, and More
• Lp(a): The Cholesterol You Might Not Know About
• The Coronary Calcium Score
• CT Coronary Angiogram (CTCA): What It Is and What to Expect
• Statins and Coronary Calcium Scores: What the Research Shows

This article is for general educational purposes only and does not constitute individual medical advice. Please discuss your specific circumstances with your treating cardiologist or GP.